New CRISPR Method Allows Precise Control of Protein Production in Cells

On July 8, 2026, a team of researchers from Ludwig Maximilian University of Munich unveiled a groundbreaking CRISPR-based method named TAPIR (Targeted Activation of Protein Translation) that enables precise control of protein production in cells. Led by Professor Stefan H. Stricker, this research highlights the direct regulation of ribosomal RNA (rRNA) and its implications in various diseases.

Understanding the Role of Ribosomal RNA

Ribosomal RNA plays a crucial role in protein synthesis, impacting whether a cell divides, specializes, or maintains its stem cell properties. The study published in Science establishes that the quantity of rRNA can significantly influence these cellular processes. Stricker emphasized, "Our new study shows that targeted activation of rRNA production significantly increases protein synthesis." This finding sheds light on the relationship between rRNA levels and cellular function.

Previously, it was unclear whether variations in rRNA levels among different cell types were a cause or a consequence of biological processes. The TAPIR method allows researchers to enhance ribosomal gene activity, thereby influencing protein production.

Implications for Rare Diseases and Cancer

The research findings have significant implications for conditions where ribosome function is compromised, such as ribosomopathies. One example is Treacher-Collins syndrome, a rare congenital disorder that leads to facial malformations. In a mouse model, the researchers successfully stimulated rRNA production, partially compensating for disease-related alterations.

Additionally, the team discovered that similar mechanisms are involved in pancreatic cancer. Tumor cells appear to utilize increased rRNA production to sustain rapid growth. In their mouse model, TAPIR was shown to boost rRNA production, promoting cancer cell proliferation. This indicates that elevated rRNA production is a causal factor in tumor growth rather than merely a side effect.

Future Research Directions and Therapeutic Potential

Stricker concluded, "Our study clearly shows that the regulation of protein biosynthesis plays a key role both in processes of development and growth and in the development of cancer." He envisions TAPIR as a platform for future research aimed at understanding the implications of protein synthesis for health and disease. This innovative approach may pave the way for new therapeutic strategies targeting diseases associated with diminished ribosome function, as well as uncovering new treatment avenues for tumors characterized by uncontrolled protein production.

Publication Details

The study, titled Manipulation of protein translation and stem cell self-renewal by CRISPR activation of rRNA transcription, was authored by Maximilian Wiesbeck et al. and published in Science in 2026. DOI: 10.1126/science.aeh1348.